Page 70 - Academic Press Encyclopedia of Physical Science and Technology 3rd Molecular Biology
P. 70

P1: GSS/GLE  P2: GPJ Final Pages
 Encyclopedia of Physical Science and Technology  EN007I-331  July 3, 2001  18:42







              Immunology—Autoimmunity                                                                     681

               TABLE I Examples of the Clinical Diagnostic Specificity of Autoantibodies a
                    Autoantibody specificity a              Molecular specificity             Clinical association
               Organ-specific autoimmune diseases
                Anti-acetylcholine receptor ∗    Acetylcholine receptor                  Myasthenia gravis
                Anti-TSh receptor ∗              TSH receptor                            Graves’ disease
                Antithyroglobulin ∗              Thyroglobulin                           Chronic thyroiditis
                Anti-thyroid peroxidase ∗        Thyroid peroxidase                      Chronic thyroiditis
                Antimitochondria ∗               Pyruvate dehydrogenase complex          Primary biliary cirrhosis
                Antikeratinoctye ∗               Desmoplakin I homologue                 Bullous pemphigoid
                Antikeratinoctye ∗               Desmoglien                              Pemphigus foliaceus
               Multisystem autoimmune diseases
                Anti-double-stranded DNA ∗       B form of DNA                           SLE
                Anti-Sm ∗                        B, B , D, and E proteins of U1, U2, and U4–U6 snRNP  SLE

                Anti-nRNP                        70-kDa, A, and C proteins of U1-snRNP   MCTD, SLE
                Anti-SS-A/Ro                     60- and 52-kDa proteins associated with the hY1–Y5  SS, neonatal lupus, SLE
                                                  RNP complex
                Anti-SS-B/La                     47-kDa phosphoprotein complexed with RNA  SS, neonatal lupus, SLE
                                                  polymerase III transcripts
                Anti-Jo-1 ∗                      Histidyl tRNA synthetase                Polymyositis
                Antifibrillarin ∗                 34-kDa protein of box C/D containing snoRNP  Scleroderma
                                                  (U3, U8, etc.)
                Anti-RNA polymerase 1 ∗          Subunits of RNA polymerase 1 complex    Scleroderma
                Anti-DNA topoisomerase 1 (anti-Scl-70) ∗  100-kDa DNA topoisomerase I    Scleroderma
                Anticentromere ∗                 Centromeric proteins CENP-A, -B, and -C  CREST (limited scleroderma)
                cANCA                            Serine proteinase (proteinase 3)        Wegener’s vasculitis

                 a  SLE, systemic lupus erythematosus; MCTD, mixed connective tissue disease; SS, Sj¨ogren’s syndrome; cANCA, cytoplasmic antineutrophil
               cytoplasmic antibody; TSH, thyroid-stimulating hormone; CREST, calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly,
               telangiectasia. Disease-specific diagnostic marker antibodies indicated by an asterisk.


              diseases  are  components  of  macromolecular  structures  SLE. Other autoantibody responses demonstrate similar
              such as the nucleosome of chromatin and the small nuclear  associations and restrictions. The anti-SS-A/Ro response
              ribonucleoprotein (snRNP) particles of the spliceosome,  (see Table I) frequently occurs alone in SLE but the anti-
              among others. Autoantibodies to different components of  SS-B/La response in Sj¨ogren’s syndrome is almost always
              the same macromolecular complex can be diagnostic for  associated with the anti-SS-A/Ro response. Similarily the
              different clinical disorders. For example, the core pro-  antichromatin response occurs alone in drug-induced lu-

              teins B, B , D, and E, which are components of the U1,  pus but is often associated with the anti-dsDNA response
              U2, and U4–U6 snRNPs and are antigenic targets in the  in idiopathic SLE. Autoantibody specificities may occur
              anti-Smith antigen (Sm) response in SLE, are different  at different frequencies in a variety of diseases, and the
              from the U1 snRNP specific proteins of 70 kDa, A, and  resulting profile consisting of distinct groups of autoan-
              C, which are targets of the anti-nuclear RNP (nRNP) re-  tibodies in different diseases can have diagnostic value.
              sponse in mixed connective tissue disease (MCTD; see  In some cases the grouping of autoantibody specificities,
              Table I). It has also been shown that particular autoanti-  such as the preponderance of antinucleolar autoantibod-
              body responses are consistently associated with one an-  ies in scleroderma (Table I), provides intriguing but as
              other. The anti-Sm response, which is diagnostic of SLE,  yet little understood relationships with clinical diagnosis.
              is commonly associated with the anti-nRNP response, but  Unlike SLE, in which a single patient may have multiple
              when the anti-nRNP response occurs in the absence of the  autoantibody specificities to a number of unrelated nuclear
              anti-Sm response it can support the diagnosis of MCTD.  autoantigens (e.g., DNA, Sm, SS-A/Ro), scleroderma pa-
              These two observations suggest that the snRNP com-  tients are less likely to have multiple autoantibody speci-
              plexes responsible for the autoantibody response against  ficities to nucleolar autoantigens that are unrelated at the
              the spliceosome in MCTD may differ from the snRNP  macromolecular level (i.e., not part of the same macro-
              complexes that produce the antispliceosome response in  molecular complex).
   65   66   67   68   69   70   71   72   73   74   75